Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04378439 · ClinicalTrials.gov registry record · NA
Appalachian Partnership to Reduce Disparities (Aim 2)
A NA study of HIV/AIDS and HCV, sponsored by Wake Forest University Health Sciences.
- Recruiting
- Registry status
- NA
- Development phase
- 141
- Enrollment target
- 1
- Study location
NCT04378439: Recruiting NA study of HIV/AIDS and HCV, sponsored by Wake Forest University Health Sciences.
NCT04378439 is a NA study of HIV/AIDS and HCV that is actively recruiting participants, run by Wake Forest University Health Sciences. The registered enrollment target is 141 participants, below the 33,178-participant average among 61 other HIV/AIDS trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04378439, a NA study of HIV/AIDS and HCV, is actively recruiting participants, sponsored by Wake Forest University Health Sciences.
- RECRUITING
- Registry status
- NA
- Development phase
- 141 participants
- Enrollment target
- 1
- Study location
Study Summary
By combining two strategies (i.e., peer navigation and mHealth) into a complete, culturally compatible, bilingual intervention to increase the use of needed HIV, STI, and HCV prevention and care services among racially/ethnically diverse GBMSM and transgender women in rural Appalachia. Study Investigators anticipate that participants in the intervention group, relative to counterparts in the delayed-intervention group, will demonstrate increased HIV, STI, and HCV testing.
Interventions
- BEHAVIORAL mHealth
- BEHAVIORAL Peer Navigation
Study Locations (1)
North Carolina
- Wake Forest University Health Sciences - Winston-Salem
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 141 participants |
| Start Date | 2022-04-01 |
| Est. Completion | 2026-05 |
| Phase | NA |
What NCT04378439 shows while recruiting
NCT04378439 is an interventional study that assigns participants to a tested intervention. The registered 141 participants enrollment target is mid-sized for trials with a published cap, below the 33,178-participant average among 61 other HIV/AIDS trials with a reported enrollment target (100% lower).
The record links to 3 conditions, with HIV/AIDS appearing as the primary indexed condition, and to 2 interventions - of which mHealth is the first listed.
NCT04378439 reports a single indexed study location in North Carolina.
Frequently Asked Questions
What is clinical trial NCT04378439 about?
NCT04378439 is a clinical study titled "Appalachian Partnership to Reduce Disparities (Aim 2)". By combining two strategies (i.e., peer navigation and mHealth) into a complete, culturally compatible, bilingual intervention to increase the use of needed HIV, STI, and HCV prevention and care services among racially/ethnically diverse GBMSM and transgender women in rural Appalachia. Study Invest...
What is the current status of trial NCT04378439?
This trial is currently recruiting. It is a NA study. The enrollment target is 141 participants. The study started on 2022-04-01. Estimated completion is 2026-05.
What conditions does trial NCT04378439 study?
This clinical trial studies the following conditions: HIV/AIDS, HCV, STI.
What interventions are being tested in trial NCT04378439?
The interventions under investigation include: mHealth (BEHAVIORAL), Peer Navigation (BEHAVIORAL).
Who is sponsoring clinical trial NCT04378439?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04378439 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for HIV/AIDS
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04378439's enrollment target sits among peer trials
141 30th of 61 higher than 31 of 61 other HIV/AIDS trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other HIV/AIDS trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Mobile Gaming App to Improve Adherence to PrEP
RECRUITING · NA
-
LinkPositively+ A Mobile Health App Delivered Intervention to Improve HIV Care Outcomes Among Black Women Affected by Mental Health and Violence
RECRUITING · NA
-
MyPEEPS Mobile Plus: A Multi-Level HIV Prevention Intervention for Young MSM
RECRUITING · NA
-
MyPEEPS LITE Trial
RECRUITING · NA
-
Project I Test: Implementing HIV Testing in Opioid Treatment Programs
RECRUITING · NA
-
Improving the Organizational Social Context to Address Structural Racism and Discrimination
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03042962 · 141 participants
Brain Networks in Dystonia
- NCT04775485 · 141 participants · Phase 2
A Study to Evaluate Tovorafenib in Pediatric and Young Adult Participants With Relapsed or Progressive Low-Grade Glioma and Advance Solid Tumors
- NCT05040360 · 141 participants · Phase 2
Testing the Use of Chemotherapy After Surgery for High-Risk Pancreatic Neuroendocrine Tumors
- NCT05814146 · 141 participants · NA
Trial of Variable Dialysate Bicarbonate
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI